ClinicalTrials.gov
public full text
Public Domain
A Study of Adjuvant Melanoma Stakeholder Treatment Preferences
The purpose of this study is to understand the trade-offs that participants with surgically treated melanoma would be willing to make among key features and outcomes of adjuvant anti-cancer treatments or no adjuvant treatment / observation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Shared Decision Making in Melanoma Patients Receiving Adjuvant Therapy#890734
- Biological Therapy in Treating Patients With Metastatic Melanoma#329503
- Vaccine Therapy in Treating Patients With Refractory Metastatic Melanoma#154746
- Study of Gene Modified Immune Cells in Patients With Advanced Melanoma#980856
- An Observational Study of Adjuvant (Post-surgery) Therapy With Nivolumab for Resected (Completely Removed) Melanoma in Australia#831912
Record · ID 1138550
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive